ScholarIQanswers from OpenAlex

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

PaperCitations, authors & open-access status

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD have?

ScholarIQcitation count

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD has 731 citations in the OpenAlex counts ScholarIQ stores.

When was A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD published?

ScholarIQyear

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD has 2001 year in the ScholarIQ index.

What is the open-access status of A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD?

ScholarIQoa status

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD has closed oa status in the ScholarIQ index.

What is the DOI of A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD?

ScholarIQdoi

The DOI for A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD is on the source record.

What is the PMID of A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD?

ScholarIQpmid

The PMID for A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD is on the source record.

What is the OpenAlex record for A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD?

ScholarIQopenalex

The OpenAlex for A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial